Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan 10:14:1065183.
doi: 10.3389/fnagi.2022.1065183. eCollection 2022.

Microglial autophagy in Alzheimer's disease and Parkinson's disease

Affiliations
Review

Microglial autophagy in Alzheimer's disease and Parkinson's disease

Zhifu Wang et al. Front Aging Neurosci. .

Abstract

Alzheimer's disease (AD) and Parkinson's disease (PD) are the most common neurodegenerative diseases, characterized by gradual and selective loss of neurons in the central nervous system. They affect more than 50 million people worldwide, and their incidence increases with age. Although most cases of AD and PD are sporadic, some are caused by genetic mutations that are inherited. Both sporadic and familial cases display complex neuropathology and represent the most perplexing neurological disorders. Because of the undefined pathogenesis and complex clinical manifestations, there is still no effective treatment for both AD and PD. Understanding the pathogenesis of these important neurodegenerative diseases is important for developing successful therapies. Increasing evidence suggests that microglial autophagy is associated with the pathogenesis of AD and PD, and its dysfunction has been implicated in disease progression. In this review, we focus on the autophagy function in microglia and its dysfunction in AD and PD disease models in an attempt to help our understanding of the pathogenesis and identifying new therapeutic targets of AD and PD.

Keywords: AD; PD; autophagy; microglia; neurodegeneration.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The mechanisms by which microglia respond to aggregated proteins. Firstly, aggregates (Aβ/Tau/α-syn) are recognized by microglial pattern recognition receptors, such as TLR2 and TLR4. Afterward, these receptor binding activates the specific signaling pathways involving MYD88/NF-κB, which leads to transcription of NLRP3 and subsequent enables the release of inflammatory cytokines, namely IL-18 and IL-β. Further, the release of cytokines will induce chronic inflammatory responses.
Figure 2
Figure 2
The mechanism of microglial synucleinphagy. Microglia ingest extracellular α-syn protein, which is sequestered by the autophagy-lysosome pathway. This process is mediated through TLR4-NF-κB signaling, and leads to the endocytosis- and phago-independent ingestion of extracellular α-syn. In this process, α-syn-TLR4 interaction stimulates p62 expression mediated by NF-κB. Meanwhile, α-syn can enter the cells or penetrate cytoplasmic membrane through other endocytosis-independent processes [such as lipid raft (Park et al., 2009)] or endocytosis-dependent processes (Lee et al., 2008a). Then, oligomeric p62 binds and recruits ubiquitinated-α-Syn (Ub-α-Syn) into autophagosomes for degradation.

Similar articles

Cited by

References

    1. Abiega O., Beccari S., Diaz-Aparicio I., Nadjar A., Layé S., Leyrolle Q., et al. . (2016). Neuronal hyperactivity disturbs ATP microgradients, impairs microglial motility, and reduces phagocytic receptor expression triggering apoptosis/microglial phagocytosis uncoupling. PLoS Biol. 14:e1002466. doi: 10.1371/journal.pbio.1002466, PMID: - DOI - PMC - PubMed
    1. Ahmed S., Kwatra M., Ranjan Panda S., Murty U. S. N., Naidu V. G. M. (2021). Andrographolide suppresses NLRP3 inflammasome activation in microglia through induction of parkin-mediated mitophagy in in-vitro and in-vivo models of Parkinson disease. Brain Behav. Immun. 91, 142–158. doi: 10.1016/j.bbi.2020.09.017, PMID: - DOI - PubMed
    1. Aloisi F. (2001). Immune function of microglia. Glia 36, 165–179. doi: 10.1002/glia.1106 - DOI - PubMed
    1. Alonso A. D., Cohen L. S., Corbo C., Morozova V., ElIdrissi A., Phillips G., et al. . (2018). Hyperphosphorylation of tau associates with changes in its function beyond microtubule stability. Front. Cell. Neurosci. 12:338. doi: 10.3389/fncel.2018.00338, PMID: - DOI - PMC - PubMed
    1. Anglade P., Vyas S., Hirsch E. C., Agid Y. (1997). Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol. 12, 603–610. - PubMed

LinkOut - more resources